Sem Sælands vei 3
PharmaSafe logo files can be downloaded here.
Migraine is highly prevalent among women of fertile age. The main objectives of this study were to describe the prevalence and patterns of use of antimigraine medications during pregnancy and breastfeeding and to identify maternal and migraine-related factors associated with medication use during pregnancy.
New article in Titan: Scientists have developed new tools and data sets that provide accurate information on how pregnant women can use medicine safely.
New article by PharmaTox postdoc Mollie Wood published on BMJ open.
Short term use of paracetamol in pregnancy seems safe, but long-term use was associated with delayed psychomotor development in the latest MoBa study.
Several PharmaSafe researchers attended the 32nd International Conference on Pharmacoepidemiology & Therapeutic Risk Management August 25-28 in Dublin which was organized by the International Society of PharmacoEpidemiology (ISPE).
We welcome Lene Sundbakk!
Read about Lene's background.
A new study shows Paracetamol use during pregnancy increases the risk of hyperactivity in children. Professor Hedvig Nordeng confirms that such results have been seen in three previous studies.
Professor Pauline Norris from University of Otago in New Zealand is collaborating with PharmaSafe researchers Ingunn Björnsdottir and Anne Gerd Granås on Mystery shopping.
PharmaSafe is happy to welcome our new professor Anne Gerd Granås who started at the School of Pharmacy, UiO, August 1st.
Anna Simone Frank starts as PhD student in PharmaSafe September 1st. Welcome!
This is how she presents herself.
Icelanders are the best in the Nordic region in football, but the "Vikings" are probably at the bottom when it comes to quality of health registries
Two PharmaSafe researchers presented poster at the International Social Pharmacy Workshop (ISPW) in Aberdeen in July.
PharmaSafe and PharmaTox leader Hedvig Nordeng co-authored the new text book “Drug Utilization Research: Methods and Applications”.
PharmaSafe PhD students Gerd Marie Eskerud Harris and Bich Thuy Ha Truong participated in the ENTIS-ISoP-NFIF Training Course: «Risk assessment of drug use during pregnancy and lactation».
Dr. Jacqueline Cohen, Postdoc at Harvard T.H. Chan School of Public Health spent six weeks at the PharmaSafe group. Her research interests have now been featured on titan.no.
A recent article by the Pharmasafe group was commented on in the journal Clinical Thyroidology.
PharmaSafe members Angela Lupattelli and Mollie Wood visited the Society for Epidemiology Epidemiology Congress of the Americas in Miami, Florida from June 21-24.
The PharmaSafe group has participated in a comparative study between Serbia and Norway.
The recently published study "Effect of prenatal selective serotonin reuptake inhibitor (SSRI) exposure on birthweight and gestational age: a sibling-controlled cohort study" has now been featured on forskning.no.
Dr. Michael Twigg from the University of East Anglia, who stayed at the PharmaSafe group in September 2015 has just published a new article in the International Journal of Clinical Pharmacy
According to the new Norwegian popular science magazine Aftenposten Vitenskap (Science), PharmaSafe group leader Hedvig Nordeng is one of 25 Norwegian scientists you should have heard of.
The PharmaSafe group has published a new article in "The International Journal of Epidemiology".